These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3674173)

  • 1. Evaluation of 1-deamino-[D-Tyr(Oethyl)2, Thr4, Orn8] vasotocin, an oxytocin antagonist, in animal models of uterine contractility and preterm labor: a new tocolytic agent.
    Hahn DW; Demarest KT; Ericson E; Homm RE; Capetola RJ; McGuire JL
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):977-82. PubMed ID: 3674173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of an oxytocin antagonist, RWJ 22164 for treatment of preterm labor in laboratory models of uterine contractility.
    Demarest KT; Hahn DW; Ericson E; Capetola RJ; Fuchs AR; McGuire JL
    Am J Perinatol; 1989 Apr; 6(2):200-4. PubMed ID: 2712917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin receptor blockade: a new principle in the treatment of preterm labor?
    Andersen LF; Lyndrup J; Akerlund M; Melin P
    Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of oxytocin antagonists with prolonged action: potential tocolytic agents for the treatment of preterm labor.
    Chan WY; Hruby VJ; Rockway TW; Hlavacek J
    J Pharmacol Exp Ther; 1986 Oct; 239(1):84-7. PubMed ID: 3761199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oxytocin antagonist (dTVT) and ritodrine on spontaneous and oxytocics-induced uterine contractions in pregnant rats.
    Chimura T
    Asia Oceania J Obstet Gynaecol; 1991 Sep; 17(3):265-70. PubMed ID: 1953439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists for the human oxytocin receptor: an in vitro study.
    Maggi M; Fantoni G; Baldi E; Cioni A; Rossi S; Vannelli GB; Melin P; Akerlund M; Serio M
    J Reprod Fertil; 1994 Jul; 101(2):345-52. PubMed ID: 7932368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
    Akerlund M; Melin P; Maggi M
    Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor.
    Reinheimer TM; Bee WH; Resendez JC; Meyer JK; Haluska GJ; Chellman GJ
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2275-81. PubMed ID: 15671092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban.
    Manning M; Miteva K; Pancheva S; Stoev S; Wo NC; Chan WY
    Int J Pept Protein Res; 1995; 46(3-4):244-52. PubMed ID: 8537178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban.
    Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M
    Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin.
    Akerlund M; Carlsson AM; Melin P; Trojnar J
    Acta Obstet Gynecol Scand; 1985; 64(6):499-504. PubMed ID: 4061066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atosiban.
    Shubert PJ
    Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions.
    Goodwin TM; Millar L; North L; Abrams LS; Weglein RC; Holland ML
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):913-7. PubMed ID: 7573268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.
    Goodwin TM; Paul R; Silver H; Spellacy W; Parsons M; Chez R; Hayashi R; Valenzuela G; Creasy GW; Merriman R
    Am J Obstet Gynecol; 1994 Feb; 170(2):474-8. PubMed ID: 8116700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oxytocin inhibitor for suppressing preterm labour.
    Turnbull AC
    Br J Obstet Gynaecol; 1987 Nov; 94(11):1009-11. PubMed ID: 3426978
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturanl myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation.
    Nathanielsz PW; Honnebier MB; Mecenas C; Jenkins SL; Holland ML; Demarest K
    Biol Reprod; 1997 Aug; 57(2):320-4. PubMed ID: 9241045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new tocolytic agent: development of an oxytocin antagonist for inhibiting uterine contractions.
    Wilson L; Parsons MT; Ouano L; Flouret G
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):195-202. PubMed ID: 2375344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on prostaglandin and oxytocin activity in preterm labor.
    Ivanisević M; Djelmis J; Buković D
    Coll Antropol; 2001 Dec; 25(2):687-94. PubMed ID: 11811300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
    Croci T; Cecchi R; Marini P; Rouget C; Viviani N; Germain G; Guagnini F; Fradin Y; Descamps L; Pascal M; Advenier C; Breuiller-Fouché M; Leroy MJ; Bardou M
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.